AHSG and chronic kidney disease: Mice received intravenous bolus injections of 160 μg (fetuin-A content, equals 160 μg calcium content) of fluorescent primary or secondary CPP, an amount which should rapidly be diluted to 10 μg/ml CPP (calcium content) or below in the circulation, a concentration of circulating CPP recently observed in CKD patients (25).